Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesús F San-Miguel

Showing results (1-10 of 239) with videos related to

Pageof 24
Sort By:
Blood|July 7, 2012
Consolidation therapy in myeloma: a consolidated approach?Jesús F San-Miguel
Therapeutic Advances in Hematology|April 5, 2013
Safety and efficacy of subcutaneous formulation of bortezomib versus the conventional intravenous formulation in multiple myelomaMarìa-Victoria Mateos, Jesús F San Miguel
Hematology. American Society of Hematology. Education Program|December 10, 2017
Management of multiple myeloma in the newly diagnosed patientMaría-Victoria Mateos, Jesús F San Miguel
Current Treatment Options in Oncology|April 30, 2003
Myeloma: update on supportive care strategiesJesús F San Miguel, Ramón García-Sanz
Hematology. American Society of Hematology. Education Program|December 9, 2022
Cellular therapy for multiple myeloma: what's now and what's nextPaula Rodriguez-Otero, Jesús F San-Miguel
Investigational New Drugs|December 2, 2010
The DAC system and associations with multiple myelomaEnrique M Ocio, Jesús F San Miguel
Hematology. American Society of Hematology. Education Program|December 10, 2013
How should we treat newly diagnosed multiple myeloma patients?María-Victoria Mateos, Jesús F San Miguel
Hematology. American Society of Hematology. Education Program|December 17, 2009
How to treat a newly diagnosed young patient with multiple myelomaJesús F San-Miguel, María-Victoria Mateos
Current Hematologic Malignancy Reports|August 27, 2013
New approaches to smoldering myelomaMaría-Victoria Mateos, Jesús F San Miguel
Best Practice & Research. Clinical Haematology|July 20, 2005
Prognostic features of multiple myelomaJesús F San Miguel, Ramón García-Sanz
Pageof 24

Showing results (1-10 of 239) with videos related to

Sort By:
Pageof 24
Blood|July 7, 2012
Consolidation therapy in myeloma: a consolidated approach?Jesús F San-Miguel
Therapeutic Advances in Hematology|April 5, 2013
Safety and efficacy of subcutaneous formulation of bortezomib versus the conventional intravenous formulation in multiple myelomaMarìa-Victoria Mateos, Jesús F San Miguel
Hematology. American Society of Hematology. Education Program|December 10, 2017
Management of multiple myeloma in the newly diagnosed patientMaría-Victoria Mateos, Jesús F San Miguel
Current Treatment Options in Oncology|April 30, 2003
Myeloma: update on supportive care strategiesJesús F San Miguel, Ramón García-Sanz
Hematology. American Society of Hematology. Education Program|December 9, 2022
Cellular therapy for multiple myeloma: what's now and what's nextPaula Rodriguez-Otero, Jesús F San-Miguel
Investigational New Drugs|December 2, 2010
The DAC system and associations with multiple myelomaEnrique M Ocio, Jesús F San Miguel
Hematology. American Society of Hematology. Education Program|December 10, 2013
How should we treat newly diagnosed multiple myeloma patients?María-Victoria Mateos, Jesús F San Miguel
Hematology. American Society of Hematology. Education Program|December 17, 2009
How to treat a newly diagnosed young patient with multiple myelomaJesús F San-Miguel, María-Victoria Mateos
Current Hematologic Malignancy Reports|August 27, 2013
New approaches to smoldering myelomaMaría-Victoria Mateos, Jesús F San Miguel
Best Practice & Research. Clinical Haematology|July 20, 2005
Prognostic features of multiple myelomaJesús F San Miguel, Ramón García-Sanz
Pageof 24